TENAX THERAPEUTICS INC's ticker is and the CUSIP is 88032L209. A total of 26 filers reported holding TENAX THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $19,361 | -35.5% | 173,801 | 0.0% | 0.00% | – |
Q3 2022 | $30,000 | -72.2% | 173,801 | -51.6% | 0.00% | – |
Q2 2022 | $108,000 | -62.8% | 358,978 | 0.0% | 0.00% | – |
Q1 2022 | $290,000 | -22.5% | 358,978 | -0.3% | 0.00% | – |
Q4 2021 | $374,000 | -41.7% | 360,069 | -0.8% | 0.00% | – |
Q3 2021 | $642,000 | -13.5% | 363,069 | +1.9% | 0.00% | – |
Q2 2021 | $742,000 | +119.5% | 356,347 | +100.3% | 0.00% | – |
Q1 2021 | $338,000 | +241.4% | 177,892 | +234.1% | 0.00% | – |
Q4 2020 | $99,000 | +62.3% | 53,252 | +35.8% | 0.00% | – |
Q3 2020 | $61,000 | +454.5% | 39,227 | +221.5% | 0.00% | – |
Q2 2020 | $11,000 | +57.1% | 12,200 | 0.0% | 0.00% | – |
Q1 2020 | $7,000 | -58.8% | 12,200 | 0.0% | 0.00% | – |
Q4 2019 | $17,000 | +13.3% | 12,200 | 0.0% | 0.00% | – |
Q3 2019 | $15,000 | -11.8% | 12,200 | 0.0% | 0.00% | – |
Q2 2019 | $17,000 | -32.0% | 12,200 | 0.0% | 0.00% | – |
Q1 2019 | $25,000 | +66.7% | 12,200 | 0.0% | 0.00% | – |
Q4 2018 | $15,000 | -76.9% | 12,200 | -1.5% | 0.00% | – |
Q3 2018 | $65,000 | -16.7% | 12,388 | 0.0% | 0.00% | – |
Q2 2018 | $78,000 | +11.4% | 12,388 | -3.4% | 0.00% | – |
Q1 2018 | $70,000 | – | 12,818 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 43,164 | $61,000 | 0.02% |
FAS Wealth Partners, Inc. | 58,576 | $83,000 | 0.01% |
Gradient Investments LLC | 1 | $0 | 0.00% |
Hudock, Inc. | 1 | $0 | 0.00% |
Allworth Financial LP | 1 | $0 | 0.00% |
VANGUARD GROUP INC | 12,200 | $17,000 | 0.00% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 5,018 | $7,000 | 0.00% |
UBS Group AG | 72 | $0 | 0.00% |
IFP Advisors, Inc | 0 | $0 | 0.00% |
Advisor Group, Inc. | 3,065 | $4,000 | 0.00% |